Unique ID issued by UMIN | UMIN000008403 |
---|---|
Receipt number | R000009881 |
Scientific Title | Safety and feasibility study of Cognitive Behavioral Therapy for Obsessive Compulsive Disorder – an open-label pilot study |
Date of disclosure of the study information | 2012/07/17 |
Last modified on | 2016/07/11 12:27:57 |
Safety and feasibility study of Cognitive Behavioral Therapy for Obsessive Compulsive Disorder – an open-label pilot study
Cognitive Behavioral Therapy for Obsessive Compulsive Disorder-an open-label pilot study
Safety and feasibility study of Cognitive Behavioral Therapy for Obsessive Compulsive Disorder – an open-label pilot study
Cognitive Behavioral Therapy for Obsessive Compulsive Disorder-an open-label pilot study
Japan |
Obsessive Compulsive Disorder
Psychiatry |
Others
NO
To test safety and feasibility of Cognitive Behavioral Therapy for Obsessive Compulsive Disorder in Japanese clinical settings
Safety,Efficacy
Exploratory
Phase III
Y-BOCS (Yale-Brown Obsessive Compulsive Scale)
BDI-II(Beck Depression Inventory)
SF-36(Quality of Life Scale)
OASIS(Overall Anxiety Severity and Impairment Scale)
EQ5D(Quality of Life Scale)
QIDS-J(Quick Inventory of Depressive Symptomatology)
GRID-HAMD(GRID-Hamilton Depression Rating Scale)
MRI
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Behavior,custom | Maneuver |
Cognitive Behavioral Therapy for Obsessive Compulsive Disorder
20 | years-old | <= |
65 | years-old | >= |
Male and Female
1. Subjects with current DSM-IV Obsessive Compulsive Disorder at screening.
2. Aged 20 years or order, and 65 years or younger at screening.
3. Subjects who give full consent in the participation of the study.
1. No alcohol or substance use disorder in 6 months prior to the screening.
2. No other primary DSM-IV Axis I Disorders except Obsessive Compulsive Disorder in 6 months prior to the screening.
3. No comorbid of antisocial personality disorder.
4. No serious suicidal ideation at screening.
5. Evidence of unable to participate half or more of the intervention phase.
6. No past treatment of CBT for Obsessive Compulsive Disorder.
7. No major cognitive deficits for CBT treatment at screening.
8. No severe or unstable medical co-morbidities at screening.
9. Other relevant reason decided by the investigators.
30
1st name | |
Middle name | |
Last name | Masaru Horikoshi, Ph.D. |
National Center of Neurology and Psychiatry
Cognitive Behavioral Therapy Center
Ogawahigashi4-1-1, Kodaira, Tokyo, Japan
042-341-2712
mhorikoshi@ncnp.go.jp
1st name | |
Middle name | |
Last name | Masaru Horikoshi, Ph.D. |
National Center of Neurology and Psychiatry
Cognitive Behavioral Therapy Center
Ogawahigashi4-1-1, Kodaira, Tokyo, Japan
042-341-2712
mhorikoshi@ncnp.go.jp
Cognitive Behavioral Therapy Center OCD Study Group
Ministry of Education, Culture, Sports Science and Technology (MEXT)
Japan
NO
独立行政法人国立精神・神経医療研究センター病院
2012 | Year | 07 | Month | 17 | Day |
Unpublished
Completed
2012 | Year | 05 | Month | 18 | Day |
2012 | Year | 07 | Month | 01 | Day |
2013 | Year | 10 | Month | 01 | Day |
2013 | Year | 11 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2013 | Year | 12 | Month | 01 | Day |
2012 | Year | 07 | Month | 11 | Day |
2016 | Year | 07 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009881